Новости и публикации
To authorization applicants and manufacturers of medicinal products containing dipyridamole as an active ingredient
In connection with the letter of the Federal State Budgetary Institution "Scientific Center for [...]
On new data on the safety of the drug Ixel (INN — Milnacipran)
Added information on the possibility of developing serotonin syndrome when combined with Buprenorphine (based [...]
Information letter dated 07.10.2021 No. 01I-1295/21 About changing email addresses
The Federal Service for Surveillance in Healthcare, as part of the execution of the [...]
Safety variations for Ponatinib
After reviewing the available evidence and evaluating the evidence provided by the relevant Marketing [...]
Boequivalence studies
Bioequivalence (pharmacokinetic equivalence) is the degree of similarity of a pharmaceutically equivalent drug to [...]
National Pharmacovigilance Research Center took part in the XVII conference «Actual problems of ensuring the quality of drug and medical care»
On October 17-19, 2021, the XVII annual interregional conference "Actual problems of ensuring [...]